Pengfei Yang,Yongwei Zhang,Lei Zhang,Yongxin Zhang,Kilian M. Treurniet,Wenhuo Chen,Ya Peng,Hongxing Han,Jiyue Wang,Shouchun Wang,Congguo Yin,Sheng Liu,Peng Wang,Qi Fang,Hongchao Shi,Jianhong Yang,Changming Wen,Conghui Li,Changchun Jiang,Jun Sun,Xincan Yue,Min Lou,Meng Zhang,Hansheng Shu,Dianjing Sun,Hui Liang,Tong Li,Fuqiang Guo,Kaifu Ke,Haicheng Yuan,Guoping Wang,Weimin Yang,Huaizhang Shi,Tianxiao Li,Zifu Li,Pengfei Xing,Ping Zhang,Yu Zhou,Hao Wang,Yi Xu,Qinghai Huang,Tao Wu,Rui Zhao,Qiang Li,Yibin Fang,Laixing Wang,Jianping Lu,Yansheng Li,Jianhui Fu,Xihua Zhong,Yongjun Wang,Longde Wang,Mayank Goyal,Diederik W. J. Dippel,Bo Hong,Benqiang Deng,Yvo B. W. E. M. Roos,Charles B. L. M. Majoie,Jianmin Liu

Abstract:BACKGROUND In acute ischemic stroke, there is uncertainty regarding the benefit and risk of administering intravenous alteplase before endovascular thrombectomy. METHODS We conducted a trial at 41 academic tertiary care centers in China to evaluate endovascular thrombectomy with or without intravenous alteplase in patients with acute ischemic stroke. Patients with acute ischemic stroke from large-vessel occlusion in the anterior circulation were randomly assigned in a 1:1 ratio to undergo endovascular thrombectomy alone (thrombectomy-alone group) or endovascular thrombectomy preceded by intravenous alteplase, at a dose of 0.9 mg per kilogram of body weight, administered within 4.5 hours after symptom onset (combination-therapy group). The primary analysis for noninferiority assessed the between-group difference in the distribution of the modified Rankin scale scores (range, 0 [no symptoms] to 6 [death]) at 90 days on the basis of a lower boundary of the 95% confidence interval of the adjusted common odds ratio equal to or larger than 0.8. We assessed various secondary outcomes, including death and reperfusion of the ischemic area. RESULTS Of 1586 patients screened, 656 were enrolled, with 327 patients assigned to the thrombectomy-alone group and 329 assigned to the combination-therapy group. Endovascular thrombectomy alone was noninferior to combined intravenous alteplase and endovascular thrombectomy with regard to the primary outcome (adjusted common odds ratio, 1.07; 95% confidence interval, 0.81 to 1.40; P = 0.04 for noninferiority) but was associated with lower percentages of patients with successful reperfusion before thrombectomy (2.4% vs. 7.0%) and overall successful reperfusion (79.4% vs. 84.5%). Mortality at 90 days was 17.7% in the thrombectomy-alone group and 18.8% in the combination-therapy group. CONCLUSIONS In Chinese patients with acute ischemic stroke from large-vessel occlusion, endovascular thrombectomy alone was noninferior with regard to functional outcome, within a 20% margin of confidence, to endovascular thrombectomy preceded by intravenous alteplase administered within 4.5 hours after symptom onset. (Funded by the Stroke Prevention Project of the National Health Commission of the People's Republic of China and the Wu Jieping Medical Foundation; DIRECT-MT ClinicalTrials.gov number, NCT03469206.).

Tandem stents thrombectomy as a rescue treatment for refractory large vessel occlusions

Endovascular Thrombectomy with or Without Intravenous Alteplase in Acute Stroke

Intracranial stenting as a rescue therapy for acute anterior large vessel occlusive stroke after retrievable stent thrombectomy failure

Management of acute tandem occlusions: Stent-retriever thrombectomy with emergency stenting or angioplasty.

Rescue stent implantation for the treatment of acute ischemic stroke: initial experience in 13 patients

Endovascular Treatment for Minor Acute Ischemic Strokes with Large Vessel Occlusion

Aspiration Thrombectomy Versus Stent-Retriever Thrombectomy for the First-Pass Therapy of Intracranial Atherosclerosis-Related Large Vessel Occlusion: A Post Hoc Analysis of The Endovascular Treatment With Versus Without Tirofiban for Patients with Large Vessel Occlusion Stroke Trial

Preoperative and intraoperative tirofiban during endovascular thrombectomy in large vessel occlusion stroke due to large artery atherosclerosis

Rescue stenting after the failure of mechanical thrombectomy to treat acute intracranial atherosclerotic occlusion

Balloon Angioplasty Combined with Tirofiban as a First-Line Rescue Treatment After Failed Mechanical Thrombectomy for Middle Cerebral Artery Occlusion with Underlying Atherosclerosis

Solitaire stent in the treatment of acute ischemic stroke with large cerebral artery occlusion

Safety and efficacy of tirofiban combined with intravenous thrombolysis and endovascular treatment in acute large vessel occlusion stroke

Effect analysis of Solitaire FR stent mechanical thrombectomy combined with 5F Navien catheter aspiration technique for the treatment of acute middle cerebral artery occlusion

Abstract TMP85: Endovascular Thrombectomy for Large Ischemic Strokes With Tandem Lesions: A SELECT2 Subanalysis

Endovascular Treatment With or Without Intravenous Thrombolysis for Acute Ischemic Stroke Due to Tandem Occlusion: A Systematic Review and Meta-Analysis

Y-Stent Rescue Technique for Failed Thrombectomy in Patients With Large Vessel Occlusion: A Case Series and Pooled Analysis

Efficacy and safety of rescue stenting following failed mechanical thrombectomy for anterior circulation large vessel occlusion: propensity score analysis.

Safety and Efficacy of Adjunct Tirofiban Treatment Following Mechanical Thrombectomy for Acute Ischemic Stroke Patients with Large Vessel Occlusion (LVO) Resulting in Successful Reperfusion.

Combined Approach to Stroke Thrombectomy Using a Novel Short Flexible Aspiration Catheter with a Stent Retriever

Adjunctive rescue therapy in acute large vessel occlusion secondary to underlying intracranial atherosclerotic disease

Rescue extracranial vertebral stenting in tandem occlusions: A preliminary Vietnamese study